$0.40
0.019[4.99%]
Last update: 5:01PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$0.40
0[0.00%]
| Open0.400 | Close0.398 |
| Vol / Avg.22.508K / 184.571K | Mkt Cap4.893M |
| Day Range0.380 - 0.400 | 52 Wk Range0.370 - 12.580 |
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bellerophon Therapeutics Stock (NASDAQ:BLPH), Key Statistics
Bellerophon Therapeutics Stock (NASDAQ: BLPH) analysis, key statistics.
Valuation Measures
Enterprise Value
-10.3M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.7
Price / Book (mrq)
0.83
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-330.71%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.46
Tangible Book value per share
0.46
Total Liabilities (Quarterly)
5.6M
Total Assets
11.2M
Total Liabilities
5.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -